Centaurus Financial, Inc. Abiomed Inc Transaction History

Centaurus Financial, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$224.73 - $338.64 $67,419 - $101,592	-300 Reduced 27.27%	800 $198,000
Q3 2021 Nov 12, 2021	BUY	$310.19 - $376.2 $62,038 - $75,240	200 Added 22.22%	1,100 $358,000
Q1 2021 Apr 30, 2021	BUY	$285.92 - $355.13 $4,574 - $5,682	16 Added 1.81%	900 $287,000
Q4 2020 Jan 25, 2021	BUY	$251.88 - $324.2 $7,556 - $9,726	30 Added 3.51%	884 $287,000
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $90,347 - $112,218	354 Added 70.8%	854 $237,000
Q2 2020 Aug 13, 2020	BUY	$141.4 - $257.09 $70,700 - $128,544	500 New	500 $121,000
Q3 2018 Nov 05, 2018	SELL	$354.53 - $449.75 $177,974 - $225,774	-502 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$278.07 - $446.21 $139,591 - $223,997	502 New	502 $205,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

Stay updated on Centaurus Financial, Inc. with notifications on news.